JP2009502914A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009502914A5 JP2009502914A5 JP2008523847A JP2008523847A JP2009502914A5 JP 2009502914 A5 JP2009502914 A5 JP 2009502914A5 JP 2008523847 A JP2008523847 A JP 2008523847A JP 2008523847 A JP2008523847 A JP 2008523847A JP 2009502914 A5 JP2009502914 A5 JP 2009502914A5
- Authority
- JP
- Japan
- Prior art keywords
- disorders
- withdrawal
- substance
- withdrawal symptoms
- induced
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US2005/026439 WO2007018496A1 (en) | 2005-07-26 | 2005-07-26 | Methods for treating substance-related disorders |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2009502914A JP2009502914A (ja) | 2009-01-29 |
| JP2009502914A5 true JP2009502914A5 (https=) | 2012-03-29 |
| JP5094720B2 JP5094720B2 (ja) | 2012-12-12 |
Family
ID=35064669
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008523847A Expired - Fee Related JP5094720B2 (ja) | 2005-07-26 | 2005-07-26 | サブスタンス関連障害を処置する方法 |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP1928451B1 (https=) |
| JP (1) | JP5094720B2 (https=) |
| KR (1) | KR101199499B1 (https=) |
| CN (1) | CN101272776B (https=) |
| AT (1) | ATE538784T1 (https=) |
| AU (1) | AU2005335241B9 (https=) |
| BR (1) | BRPI0520451A2 (https=) |
| CA (1) | CA2616721C (https=) |
| EA (1) | EA019935B1 (https=) |
| ES (1) | ES2385087T3 (https=) |
| IL (1) | IL189003A0 (https=) |
| NO (1) | NO20080877L (https=) |
| WO (1) | WO2007018496A1 (https=) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2435403T3 (es) | 2005-06-08 | 2013-12-19 | Sk Biopharmaceuticals Co., Ltd. | Tratamiento de trastornos del sueño y vigilia |
| KR102173587B1 (ko) | 2009-06-22 | 2020-11-04 | 에스케이바이오팜 주식회사 | 피로의 치료 또는 예방 방법 |
| US8232315B2 (en) * | 2009-06-26 | 2012-07-31 | Sk Biopharmaceuticals Co., Ltd. | Methods for treating drug addiction and improving addiction-related behavior |
| US8895609B2 (en) | 2009-11-06 | 2014-11-25 | Sk Biopharmaceuticals Co., Ltd. | Methods for treating attention-deficit/hyperactivity disorder |
| MX350745B (es) | 2009-11-06 | 2017-09-14 | Sk Biopharmaceuticals Co Ltd * | El uso de un compuesto de carbamoilo para el tratamiento del sindrome de fibromialgia. |
| US9610274B2 (en) | 2010-06-30 | 2017-04-04 | Sk Biopharmaceuticals Co., Ltd. | Methods for treating bipolar disorder |
| US8609849B1 (en) | 2010-11-30 | 2013-12-17 | Fox Chase Chemical Diversity Center, Inc. | Hydroxylated sulfamides exhibiting neuroprotective action and their method of use |
| US9359290B2 (en) | 2013-03-13 | 2016-06-07 | Jazz Pharmaceuticals International Iii Limited | Treatment of cataplexy |
| KR102309836B1 (ko) | 2013-07-18 | 2021-10-12 | 에스케이바이오팜 주식회사 | 비만의 치료 |
| US10195151B2 (en) | 2016-09-06 | 2019-02-05 | Jazz Pharmaceuticals International Iii Limited | Formulations of (R)-2-amino-3-phenylpropyl carbamate |
| AU2018278332B2 (en) | 2017-06-02 | 2022-05-19 | Jazz Pharmaceuticals Ireland Limited | Methods and compositions for treating excessive sleepiness |
| CN114096314A (zh) * | 2019-06-27 | 2022-02-25 | 沼泽敏彦 | 痴呆症的治疗和预防药 |
| US10940133B1 (en) | 2020-03-19 | 2021-03-09 | Jazz Pharmaceuticals Ireland Limited | Methods of providing solriamfetol therapy to subjects with impaired renal function |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3313692A (en) * | 1958-04-21 | 1967-04-11 | Armour Pharma | Method of inducing calming and muscle relaxation with carbamates |
| CN1262272C (zh) * | 2001-02-27 | 2006-07-05 | 奥索-麦克尼尔药品公司 | 用于预防或治疗运动障碍的氨基甲酸酯化合物 |
| PL364640A1 (en) * | 2001-02-27 | 2004-12-13 | Ortho-Mcneil Pharmaceutical, Inc. | Carbamate compounds for use in preventing or treating bipolar disorder |
| US6541513B2 (en) * | 2001-02-27 | 2003-04-01 | Ortho-Mcneil Pharmaceutical, Inc. | Carbamate compounds for use in preventing or treating psychotic disorders |
| PL364680A1 (en) * | 2001-02-27 | 2004-12-13 | Ortho-Mcneil Pharmaceutical, Inc. | Carbamate compounds for use in preventing or treating neurodegenerative disorders |
| US20070021500A1 (en) * | 2005-07-12 | 2007-01-25 | Twyman Roy E | Methods for neuroprotection |
-
2005
- 2005-07-26 AU AU2005335241A patent/AU2005335241B9/en not_active Ceased
- 2005-07-26 KR KR1020087004533A patent/KR101199499B1/ko not_active Expired - Lifetime
- 2005-07-26 ES ES05775692T patent/ES2385087T3/es not_active Expired - Lifetime
- 2005-07-26 WO PCT/US2005/026439 patent/WO2007018496A1/en not_active Ceased
- 2005-07-26 AT AT05775692T patent/ATE538784T1/de active
- 2005-07-26 EA EA200800422A patent/EA019935B1/ru not_active IP Right Cessation
- 2005-07-26 BR BRPI0520451-8A patent/BRPI0520451A2/pt not_active Application Discontinuation
- 2005-07-26 CA CA2616721A patent/CA2616721C/en not_active Expired - Lifetime
- 2005-07-26 JP JP2008523847A patent/JP5094720B2/ja not_active Expired - Fee Related
- 2005-07-26 CN CN200580051664XA patent/CN101272776B/zh not_active Expired - Fee Related
- 2005-07-26 EP EP05775692A patent/EP1928451B1/en not_active Expired - Lifetime
-
2008
- 2008-01-24 IL IL189003A patent/IL189003A0/en unknown
- 2008-02-19 NO NO20080877A patent/NO20080877L/no not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009502914A5 (https=) | ||
| Dome et al. | Smoking, nicotine and neuropsychiatric disorders | |
| Kumru et al. | Rapid eye movement sleep behavior disorder in parkinsonism with parkin mutations | |
| Murray et al. | Insomnia caused by serotonin depletion is due to hypothermia | |
| Scammell et al. | Orexin receptors: pharmacology and therapeutic opportunities | |
| Mahowald et al. | Parasomnias | |
| Karila et al. | GHB and synthetic cathinones: clinical effects and potential consequences | |
| JP6421185B2 (ja) | ベンゾイミダゾール−プロリン誘導体の使用 | |
| JP2009513672A5 (https=) | ||
| AU2021206771B2 (en) | Cognitive disorder prevention and therapy | |
| JP2017535612A5 (https=) | ||
| JP2005523335A5 (https=) | ||
| WO2008048410A3 (en) | Diagnostic methods and genetic markers for alzheimer disease | |
| Niaura et al. | Varenicline | |
| JP2019511548A5 (https=) | ||
| CN117500788A (zh) | 作为血清素能药物的用于治疗与之相关的疾病的吲哚衍生物 | |
| Szily et al. | Designer drugs in psychiatric practice-a review of the literature and the recent situation in Hungary | |
| Manconi et al. | Pramipexole versus ropinirole: polysomnographic acute effects in restless legs syndrome | |
| JP2008526706A5 (https=) | ||
| Kjellgren et al. | The quest for well-being and pleasure: experiences of the novel synthetic opioids AH-7921 and MT-45, as reported by anonymous users online. | |
| JP2010505919A5 (https=) | ||
| CA2672920A1 (en) | Aryl piperazine derivatives useful for the treatment of neuropsychiatric disorders | |
| JP2006519251A5 (https=) | ||
| Patel et al. | Effect of alcohol on brain development | |
| Khurshid et al. | THE MULTIDIMENSIONAL EFFECTS OF METHAMPHETAMINE ON YOUTH IN PAKISTAN: A COMPREHENSIVE ANALYSIS |